Les Meilleures Cliniques et Coûts des traitements d'hépatite virale en Ukraine 2026

Antiviral treatment for hepatitis C is free in Ukraine for citizens via state-funded programs. Patients can access direct-acting antivirals like Sofosbuvir at public healthcare institutions. Significant barriers like medication queues and limited supply remains common. Diagnostic tests are often self-funded at private labs.

• Program coverage: State programs provide direct-acting antivirals at no cost to eligible citizens.
• Diagnostic costs: Patients usually pay out-of-pocket for HCV RNA PCR and genotype testing.
• Access barriers: Limited drug supplies often lead to waiting lists exceeding 6 months.
• Retail alternatives: Generic courses are available for roughly $90 for those skipping queues.

Bookimed Expert Insight: Ukraine ranks 4th globally in our network for treatment requests, showing high demand despite regional instability. Centers like Impuls Medical Center in Kyiv maintain 25 doctors and internal labs. This infrastructure helps bypass public system delays for diagnostic confirmation before starting state therapy.

Patient Consensus: Patients highlight that while medicine is free, getting onto the official registry requires patience. Many suggest having genotype and Fibroscan tests ready immediately to speed up the enrollment process.

The war in Ukraine reduced functional hepatitis C treatment centers by 65%. Nearly one in 10 health facilities has been damaged. National treatment funding dropped from 18,000 to approximately 10,000 patients yearly. Logistical barriers and infrastructure destruction currently limit access to essential diagnostics and care.

• Facility reduction: Only 80 of 230 institutions remain operational for hepatitis C care.
• Budget cuts: Security costs reduced the national hepatitis C treatment capacity by 6,000 patients.
• Treatment adaptation: Organizations now dispense full courses to prevent interruptions during patient displacement.
• Diagnostic delays: Private lab closures and evacuations have extended PCR testing times to months.

Bookimed Expert Insight: Private medical centers in Kyiv have adapted to infrastructure threats by installing high-powered diesel generators. Facilities like Impuls Medical Center maintain in-house laboratories and oxygen supply points. This ensures diagnostic continuity even during regional energy blackouts typical in wartime conditions.

Patient Consensus: Patients note that traveling to western regions like Lviv often provides more stable medication access. Many warn against using black market generics and emphasize using mobile health units for initial screenings.

Ukraine utilizes modern direct-acting antivirals like Sofosbuvir and Daclatasvir to treat hepatitis C. These pangenotypic medications achieve cure rates between 94% and 98%. Most regimens last 12 to 24 weeks. Therapy is highly effective even for patients with HIV co-infections.

• Core regimens: Sofosbuvir combined with Daclatasvir or Velpatasvir treats all virus genotypes.
• Success rates: Clinical data shows sustained virologic response in over 95% of patients.
• Treatment duration: Most oral therapies require 12 weeks to achieve a full cure.
• Co-infection efficacy: Patients with HIV maintain high cure rates of approximately 93.6% to 95%.

Bookimed Expert Insight: While Ukraine has 55 clinics serving hepatitis patients, the high volume of requests reveals a trend. Specialists like Dr. Tsios Yuri Anatolievich at Impuls Medical Center in Kyiv integrate infectious disease expertise with gastroenterology. This dual focus is crucial because successful antiviral therapy often requires monitoring liver regeneration alongside virus clearance. Our data shows that top clinics now prioritize multidisciplined doctors to manage these complex recovery phases.

Patient Consensus: Patients emphasize using only verified pharmacy generics to avoid counterfeit risks. Many note that side effects are minimal, usually limited to mild fatigue during the 12-week course.

Integrated care for HIV and hepatitis C (HCV) co-infection combines screening and therapy into single-visit models. These programs utilize Direct-Acting Antivirals (DAAs) alongside antiretroviral therapy (ART). Ukraine provides specialized hubs in Kyiv and Odessa that link electronic health records to prioritize co-infected patients for treatment.

• One-stop clinics: Patients receive HIV and HCV services during the same medical consultation.
• Direct-acting antivirals: Protocols include medications like glecaprevir and pibrentasvir to treat hepatitis C.
• Fibrosis monitoring: Clinics use non-invasive scans to assess liver health before starting treatment.
• Harm reduction hubs: Programs bundle needle exchanges with rapid testing and medication dispensing.

Bookimed Expert Insight: Quality indicators for integrated care often depend on patient volume and specialized infrastructure. Clinics like Impuls Medical Center in Kyiv serve 6,000 patients annually using a polyclinic model. This high volume allows for centralized multidisciplinary teams that manage complex drug-drug interactions effectively. Integrated centers with on-site laboratories ensure faster baseline testing. This significantly reduces the time between diagnosis and starting DAAs.

Patient Consensus: Patients note that using dedicated mobile apps helps locate sites with active medication stocks. They emphasize checking fibrosis levels early to speed up treatment approvals in city-based centers.

Ukrainian refugees can access Hepatitis C therapy through national healthcare systems in the European Union. Most member states offer free direct-acting antivirals under Temporary Protection. Access usually requires registration at local administrative offices. This status grants rights equal to local insured citizens.

• Poland access: Refugees receive free diagnosis and direct-acting antiviral treatment. A GP referral is required.
• Germany care: Registered refugees access advanced liver care at centers like Charite Berlin university hospital.
• United Kingdom: New arrivals are exempt from National Health Service charges for chronic condition treatments.
• Moldova protocol: Universal medical insurance funds provide testing and treatment under the same local conditions.

Bookimed Expert Insight: While European public systems offer free care, local waiting lists for specialists can be long. In Ukraine, Impuls Medical Center in Kyiv remains active for those returning. Dr. Tsios Yuri Anatolievich specializes in infectious diseases there. The clinic maintains its own laboratory and power generators to ensure diagnostic continuity despite infrastructure challenges.

Patient Consensus: Patients emphasize registering for temporary protection immediately to secure the fastest access to medications. Many suggest using nongovernmental organization apps to locate clinics if they need to travel between different countries.